NCADD ESGPV Blog

Local News and Information
1 minute reading time (184 words)

Collaborative Care Shows Promise for Opioid and Alcohol Use Disorders

36830495

A NIDA-funded randomized clinical trial found that primary care patients with opioid and alcohol use disorders (OAUD) who were offered a collaborative care intervention were more likely to receive evidence-based treatment and refrain from using opioids and alcohol six months later, compared to patients receiving usual care.

The collaborative care intervention increased both the proportion of patients receiving evidence-based treatment for OAUD (39.0% vs. 16.8%) and the number refraining from opioids or alcohol use at six months. (32.8% vs. 22.3%).

Collaborative care was designed to increase the delivery of either a six-session brief psychotherapy treatment, and/or medication-assisted treatment, with either buprenorphine/naloxone for opioid use disorders or long-acting injectable naltrexone for alcohol use disorders. Usual care participants were given a number for appointment scheduling and a list of community referrals for OAUD treatment.

The authors suggest the findings indicate that treatment for OAUDs can be integrated into primary care settings effectively.

For a copy of the paper go to — "Collaborative Care for Opioid and Alcohol Use Disorders in Primary Care: The SUMMIT Randomized Clinical Trial"— published in JAMA Internal Medicine.

Original author: Ezra
×
Stay Informed

When you subscribe to the blog, we will send you an e-mail when there are new updates on the site so you wouldn't miss them.

“It all comes down to your choices.”
Bev Haberle, Executive Director of The Council Of ...
 

Comments

No comments made yet. Be the first to submit a comment
Already Registered? Login Here
Guest
Tuesday, 16 April 2024

Follow Us On

Search